Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, multicenter, fixed dose factorial study of Q8003 12 mg/8
mg and Q8003 6 mg/4 mg versus its individual morphine sulfate and oxycodone hydrochloride
components for the management of acute moderate to severe postoperative pain following
bunionectomy surgery.